Asymchem Laboratories Tianjin Co (FRA:7K90) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7K90 Asymchem Laboratories Tianjin Co Ltd FRA:7K90
89 GF Score
Price €12.80
GF Value €8.45
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Asymchem Laboratories Tianjin Co FFO per Share?

FFO per Share only applies to REITs.

FRA:7K90
89GF Score
Asymchem Laboratories Tianjin Co Ltd FRA:7K90
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Asymchem Laboratories Tianjin Co (FRA:7K90) Overvalued in 2026?

Based on GuruFocus' analysis, Asymchem Laboratories Tianjin Co stock appears to be overvalued. The current stock price of €12.80 is trading 51.5% above its estimated GF Value™ of €8.45. GuruFocus considers Asymchem Laboratories Tianjin Co to be Significantly Overvalued.

Key valuation signals for FRA:7K90:

  • FFO per Share:
  • GF Value™: €8.45 vs. price of €12.80 (51.5% above fair value)
  • GF Score™: 89/100 with 9 warning signs

No single metric tells the full story. See the FRA:7K90 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Asymchem Laboratories Tianjin Co Business Description

Address No. 6 Dongting 3rd Street, Economic and Technological Development Zone, Tianjin, CHN, 300457
Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development and manufacturing organization solutions throughout the drug development and manufacturing process. The group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing, which focus on innovation and commercial application of pharmaceutical technology. It has geographic areas in the Chinese Mainland and Overseas.
89GF Score

Get the complete analysis for FRA:7K90

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.80
Price
€8.45
GF Value